This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 852 |
covid-19 | patients | 180 |
novel | coronavirus | 115 |
present | study | 86 |
- | analysis | 77 |
covid-19 | infection | 62 |
- | sars | 57 |
- | time | 55 |
viral | infection | 47 |
higher | risk | 43 |
several | studies | 34 |
covid-19 | group | 31 |
previous | studies | 31 |
- | cell | 29 |
- | risk | 29 |
- | year | 29 |
viral | infections | 29 |
- | injury | 26 |
higher | levels | 25 |
clinical | data | 23 |
high | risk | 21 |
respiratory | disease | 21 |
high | levels | 19 |
other | studies | 19 |
covid-19 | cases | 18 |
severe | cases | 18 |
severe | disease | 18 |
human | coronavirus | 17 |
older | patients | 17 |
- | study | 16 |
clinical | studies | 15 |
respiratory | diseases | 13 |
current | study | 12 |
high | level | 12 |
severe | covid-19 | 11 |
- | protein | 11 |
covid-19 | infections | 10 |
first | case | 10 |
lower | levels | 10 |
previous | study | 10 |
available | data | 10 |
potential | risk | 9 |
respiratory | infection | 9 |
respiratory | viruses | 9 |
severe | coronavirus | 9 |
viral | proteins | 8 |
different | time | 8 |
previous | treatment | 8 |
inflammatory | cells | 8 |
different | levels | 8 |
covid-19 | disease | 8 |
- | coronavirus | 8 |
- | analyses | 8 |
higher | level | 7 |
human | proteins | 7 |
respiratory | infections | 7 |
- | patient | 7 |
- | covid-19 | 7 |
- | infection | 6 |
clinical | study | 6 |
human | cells | 6 |
other | viruses | 6 |
positive | cells | 6 |
severe | patients | 6 |
other | diseases | 5 |
more | patients | 5 |
low | level | 5 |
other | patients | 5 |
severe | infections | 5 |
lower | level | 5 |
high | number | 5 |
inflammatory | factors | 5 |
current | sars | 5 |
- | treatment | 5 |
- | level | 5 |
- | cells | 5 |
inflammatory | disease | 5 |
other | cases | 4 |
viral | protein | 4 |
severe | sars | 4 |
several | factors | 4 |
present | analysis | 4 |
positive | sars | 4 |
other | disease | 4 |
other | factors | 4 |
inflammatory | diseases | 4 |
human | diseases | 4 |
higher | injury | 4 |
first | study | 4 |
first | day | 4 |
covid-19 | patient | 4 |
- | infections | 4 |
human | studies | 4 |
several | times | 3 |
other | coronavirus | 3 |
potential | risks | 3 |
several | diseases | 3 |
significant | time | 3 |
severe | infection | 3 |
severe | injuries | 3 |
significant | number | 3 |
specific | treatment | 3 |
novel | virus | 3 |
more | cases | 3 |
medical | treatment | 3 |
low | number | 3 |
low | levels | 3 |
highest | number | 3 |
first | time | 3 |
early | infection | 3 |
current | covid-19 | 3 |
clinical | group | 3 |
- | years | 3 |
lower | risk | 3 |
other | group | 2 |
other | treatments | 2 |
other | time | 2 |
other | patient | 2 |
more | studies | 2 |
other | cells | 2 |
novel | viruses | 2 |
novel | sars | 2 |
positive | health | 2 |
positive | cases | 2 |
previous | model | 2 |
positive | result | 2 |
positive | results | 2 |
presents | patients | 2 |
previous | infection | 2 |
respiratory | health | 2 |
severe | injury | 2 |
significant | risk | 2 |
specific | patient | 2 |
such | data | 2 |
such | patients | 2 |
more | data | 2 |
lowest | risk | 2 |
inflammatory | protein | 2 |
covid-19 | groups | 2 |
human | sars | 2 |
- | factor | 2 |
- | factors | 2 |
- | health | 2 |
- | patients | 2 |
acute | infection | 2 |
clinical | disease | 2 |
clinical | models | 2 |
clinical | risk | 2 |
- | virus | 2 |
current | data | 2 |
different | cells | 2 |
different | days | 2 |
earliest | cases | 2 |
first | cases | 2 |
first | covid-19 | 2 |
first | studies | 2 |
higher | number | 2 |
current | treatment | 2 |
highest | risk | 2 |
present | infection | 1 |
potential | factors | 1 |
potential | sars | 1 |
potential | treatments | 1 |
present | data | 1 |
previous | sars | 1 |
presented | covid-19 | 1 |
presented | data | 1 |
presenting | cell | 1 |
presenting | cells | 1 |
previous | studied | 1 |
positive | patient | 1 |
positive | patients | 1 |
other | analyses | 1 |
other | treatment | 1 |
other | study | 1 |
other | sars | 1 |
other | risk | 1 |
other | models | 1 |
other | model | 1 |
other | injuries | 1 |
other | groups | 1 |
other | data | 1 |
respiratory | virus | 1 |
novel | treatment | 1 |
novel | protein | 1 |
respiratory | sars | 1 |
severe | case | 1 |
several | case | 1 |
several | cases | 1 |
viral | diseases | 1 |
viral | disease | 1 |
such | studies | 1 |
such | factors | 1 |
specific | time | 1 |
specific | sars | 1 |
specific | model | 1 |
specific | injuries | 1 |
specific | health | 1 |
specific | disease | 1 |
specific | analysis | 1 |
significant | injury | 1 |
significant | injuries | 1 |
significant | factor | 1 |
severe | virus | 1 |
severe | groups | 1 |
severe | group | 1 |
more | patient | 1 |
several | risk | 1 |
several | patients | 1 |
several | models | 1 |
several | levels | 1 |
several | groups | 1 |
several | disease | 1 |
several | days | 1 |
more | time | 1 |
human | protein | 1 |
medical | risk | 1 |
earlier | cases | 1 |
different | studies | 1 |
different | results | 1 |
different | groups | 1 |
current | health | 1 |
current | analysis | 1 |
covid-19 | treatment | 1 |
covid-19 | study | 1 |
covid-19 | risk | 1 |
covid-19 | coronavirus | 1 |
clinical | results | 1 |
clinical | cases | 1 |
available | treatments | 1 |
available | studies | 1 |
available | case | 1 |
acute | sars | 1 |
acute | coronavirus | 1 |
- | results | 1 |
- | resulting | 1 |
- | proteins | 1 |
- | modelling | 1 |
- | model | 1 |
- | groups | 1 |
- | disease | 1 |
- | days | 1 |
- | case | 1 |
earlier | case | 1 |
earlier | virus | 1 |
medical | analyses | 1 |
early | case | 1 |
lower | numbers | 1 |
lower | health | 1 |
low | risk | 1 |
low | health | 1 |
inflammatory | treatment | 1 |
inflammatory | proteins | 1 |
inflammatory | injury | 1 |
inflammatory | cell | 1 |
human | infection | 1 |
human | health | 1 |
human | cases | 1 |
human | case | 1 |
highest | levels | 1 |
highest | level | 1 |
higher | numbers | 1 |
higher | covid-19 | 1 |
high | numbers | 1 |
high | model | 1 |
first | year | 1 |
first | patient | 1 |
first | level | 1 |
first | cell | 1 |
early | treatment | 1 |
early | studies | 1 |
early | cases | 1 |
viral | factor | 1 |